Avanza Fonder’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,343	Closed	-$258K	–	467
2025 Q1	$258K	Sell	35,343 -722	-2%	-$5.27K	0.01%	405
2024 Q4	$421K	Buy	+36,065	New	+$421K	0.01%	374